For instance, in glioma, the activity of O6-methylguanine-DNA methyltransferase (MGMT) is positively correlated with resistance to temozolomide (TMZ), highlighting the potential role of methylation modifications in tumor drug resistance (13). This evidence concerns the gene MGMT and central nervous system cancer.